Schroder Investment Management Group Purchases 2,320 Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT)

Schroder Investment Management Group increased its holdings in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 72.4% during the fourth quarter, Holdings Channel reports. The fund owned 5,523 shares of the biotechnology company’s stock after purchasing an additional 2,320 shares during the period. Schroder Investment Management Group’s holdings in Sarepta Therapeutics were worth […]